BioSpace News Archive

Mentice AB announces that the company will present its interim report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFO Gunilla Andersson.

Greenwich LifeSciences, Inc. announced that Snehal Patel, CEO of Greenwich LifeSciences, will participate in the following upcoming investor, partnering, and scientific conferences.

JW Therapeutics (HKEx: 2126), announced the Investigational New Drug (IND) clearance from the National Medical Products Administration (NMPA) of China for the study of the anti-CD19 autologous chimeric antigen receptor T (CAR-T) cell immunotherapy product Carteyva®.

Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm,’ announced today a peer-reviewed publication in Leukemia, a leading oncology and hematology journal, entitled “GM-CSF disruption in CART cells modulates T cell activation and enhances CART cell anti-tumor activity.”

Phanes Therapeutics, Inc., an emerging leader in innovative discovery research and development in immuno-oncology, revealed that the company has completed the manufacturing scale production of a bispecific antibody constructed with its PACbody™ and SPECpair™ technologies.

Merck today announced that Joseph Romanelli will lead Human Health International, and join Merck’s Executive Team, effective August 1, 2022.

Navidea Biopharmaceuticals, Inc. today announced the results of an updated third-party asset valuation of its Rheumatoid Arthritis (“RA”) diagnostic product candidate for both the U.S. and EU markets.

HOOKIPA Pharma Inc. today announced the appointment of Tim Reilly, Ph.D. to its Board of Directors, effective immediately.

Windtree Therapeutics, Inc. today announced positive primary results with istaroxime in rapidly raising systolic blood pressure, the critical clinical objective in treating patients in cardiogenic shock.

CareDx, Inc today announced a leading presence at the International Society for Heart and Lung Transplantation (ISHLT) Annual Meeting and Scientific Sessions, with over 25 oral presentations and posters covering the latest innovations in heart and lung transplant surveillance and two symposia.